{"schema_version":"1","generated_at":"2026-11-04T19:43:52.458Z","data_as_of":null,"url":"https://www.findmykol.com/kol/eugenia-chang","json_url":"https://www.findmykol.com/kol/eugenia-chang/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"eugenia-chang","name":"Eugenia Chang","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Saint Luke's Health System","institution_url":"https://www.findmykol.com/institution/saint-luke-s-health-system","city":"Boise","state":"ID","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1326000183","openalex":"A5102680823"},"summary":"Eugenia Chang is an Oncology physician affiliated with Saint Luke's Health System. OpenAlex indexes 12 publications with 603 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":12,"cited_by_count":603,"h_index":6,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":10,"shown":3,"withheld":7,"rows":[{"payer":"Novo Nordisk Inc","program_year":2025,"amount_usd":64.54,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326000183"},{"payer":"Novo Nordisk","program_year":2023,"amount_usd":10731.32,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326000183"},{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2023,"amount_usd":124.74,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326000183"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1326000183","source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Other","share_pct":100,"classes_total":1,"classes":[{"class":"Iron Chelator","setting":"prescribed","share_pct":100,"drugs":[{"name":"Ferriprox (2 Times A Day)","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":12,"shown":5,"withheld":7,"matched_by":"OpenAlex author record","recent":[{"title":"Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial","year":2024,"journal":"Genome Medicine","source_url":"https://doi.org/10.1186/s13073-024-01297-5","status":"verified"},{"title":"Site research infrastructure and institutional performance: A report from the Voting Body of the Children’s Oncology Group (COG).","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.e23113","status":"verified"},{"title":"GO-8: Stable Expression of Factor VIII over 5 Years Following Adeno-Associated Gene Transfer in Subjects with Hemophilia a Using a Novel Human Factor VIII Variant","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-180803","status":"verified"},{"title":"Abstract CT089: Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2023-ct089","status":"verified"},{"title":"Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity","year":2018,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2018.199109","status":"verified"}],"source":"works"},"contact":{"address_1":"100 E IDAHO ST","city":"Boise","state":"ID","zip":"837126267","phone":"208-381-2782","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1326000183","source":"identity"},"similar":[{"name":"Samuel Goldlust","slug":"samuel-goldlust","institution":"Saint Luke's Health System","specialty":"Neurology","url":"https://www.findmykol.com/kol/samuel-goldlust","json_url":"https://www.findmykol.com/kol/samuel-goldlust/profile.json"},{"name":"Timothy Pluard","slug":"timothy-pluard","institution":"Saint Luke's Health System","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/timothy-pluard","json_url":"https://www.findmykol.com/kol/timothy-pluard/profile.json"},{"name":"Paul Chan","slug":"paul-chan-mo","institution":"Saint Luke's Health System","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/paul-chan-mo","json_url":"https://www.findmykol.com/kol/paul-chan-mo/profile.json"},{"name":"Bartosz Grobelny","slug":"bartosz-grobelny","institution":"Saint Luke's Health System","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/bartosz-grobelny","json_url":"https://www.findmykol.com/kol/bartosz-grobelny/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":7,"publications":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-03-14","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}